Related Experiment Video
Updated: Feb 4, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and
Nathan Ford1, Roz Scourse2, Maud Lemoine3
1Department of HIV and Global Hepatitis Program World Health Organization Geneva Switzerland.
Insights
High adherence to hepatitis B virus (HBV) antiviral therapy is crucial for successful treatment outcomes. A meta-analysis of 30 studies found overall patient adherence to be 74.6%.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Chronic hepatitis B virus (HBV) infection requires long-term antiviral therapy.
- Patient adherence to treatment is essential for achieving successful outcomes and preventing disease progression.
Purpose of the Study:
- To determine the overall proportion of patients adherent to HBV antiviral therapy.
- To identify barriers to treatment adherence in chronic HBV infection.
Main Methods:
- A systematic literature search was conducted across three databases and two conference abstract collections up to January 2018.
- Data from 30 studies, including 23,823 patients, were pooled using random effects meta-analysis to calculate adherence rates.
Main Results:
- The overall adherence rate to HBV antiviral therapy was 74.6% (95% CI, 67.1%-82.1%).
- Adherence rates were comparable between high-income settings (75.1%) and low- and middle-income settings (72.9%).
- Key barriers to adherence included forgetting medication, misunderstanding its importance, and disruptions to daily routines.
Conclusions:
- Regular assessment and reporting of treatment adherence should be integrated into routine chronic HBV care.
- Further research is needed to evaluate the effectiveness of evidence-based interventions, proven for HIV and other chronic diseases, in improving HBV treatment adherence.
Abstract:
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of adherence to treatment. We searched three databases and abstracts from two conferences up to January 2018 for studies reporting the proportion of patients who were adherent to HBV antiviral therapy and pooled data using random effects meta-analysis. We included 30 studies, providing data for 23,823 patients. Overall, adherence to treatment was 74.6% (95% confidence interval [CI] 67.1%-82.1%). Adherence was similar in high-income settings (75.1%; 95% CI, 65.4%-85.0%) and in low-income and middle-income settings (72.9%; 95% CI, 57.8%-88.0%). Reported barriers to adherence included forgetting, limited understanding of the importance of adherence, and change to routine. Conclusion : There is a need to reinforce assessment and reporting of adherence as a routine part of HBV care and to assess the extent to which evidence-based interventions to improve adherence to medication for human immunodeficiency virus [HIV] and other chronic diseases are effective for HBV infection.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

